As of 2025-12-19, the Intrinsic Value of Oncolytics Biotech Inc (ONC.TO) is -1.56 CAD. This ONC.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.42 CAD, the upside of Oncolytics Biotech Inc is -209.93%.
Based on its market price of 1.42 CAD and our intrinsic valuation, Oncolytics Biotech Inc (ONC.TO) is overvalued by 209.93%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.56 - -1.56 | -1.56 | -209.93% |
| P/E | (0.02) - (0.06) | (0.03) | -102.2% |
| DDM - Stable | (3.06) - (10.45) | (6.76) | -575.8% |
| DDM - Multi | (0.05) - (0.13) | (0.07) | -105.2% |
| Market Cap (mil) | 138.32 |
| Beta | 0.89 |
| Outstanding shares (mil) | 97.41 |
| Enterprise Value (mil) | 135.15 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.91% |
| Cost of Debt | 5.00% |
| WACC | 8.88% |